{{expand|time=2014-03-06T08:06:06+00:00}}
{{expert|time=2014-03-06T08:06:06+00:00}}
{{Drugbox
| IUPAC_name = isopropyl (5''Z'')-7-<nowiki/>{(1''R'',2''R'',3''R'',5''S'')-2-[(1''E'')-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate
| image = Tafluprost_structure.svg

<!--Clinical data-->
| tradename = Saflutan, Taflotan, Tapros, Zioptan
| Drugs.com = {{drugs.com|international|tafluprost}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = Topical ([[eye_drop|eye drop]]s)

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 209860-87-7
| CAS_number_Ref = {{ebicite|changed|??}}
| ATC_prefix = S01
| ATC_suffix = EE05
| ATC_supplemental =  
| PubChem = 6433101
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 66899
| DrugBank =  
| ChEMBL = 1963683
| ChemSpiderID = 8044182
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1O6WQ6T7G3

<!--Chemical data-->
| chemical_formula =  
| C=25 | H=34 | F=2 | O=5 
| molecular_weight = 452.531266 g/mol
| smiles = CC(C)OC(=O)CCC\C=C/CC(C(O)CC1O)C1\C=C\C(F)(F)COc2ccccc2
| InChI = 1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1
}}
{{medical}}
'''他氟前列素'''（{{lang-en|Tafluprosttrade}}，商品名：{{lang|en|Taflotan}}）是一种{{le|前列腺素类似物|prostaglandin analogue}}，作为局部用药（如[[眼藥水|眼藥水]]）来控制[[青光眼|青光眼]]缓解{{le|高眼压|ocular hypertension}}。它通过促进[[房水|房水]]外流来降低[[眼压|眼压]]<ref>Schubert-Zsilavecz, M, Wurglics, M, ''Neue Arzneimittel 2008/2009''</ref><ref>{{Cite web |url=http://www.santen.eu/index/news/07052008_Santen_Oy_Receives_Marketing_Authorization.html |title=Santen Home Page |accessdate=2014-03-06 |archive-date=2012-02-18 |archive-url=https://web.archive.org/web/20120218142920/http://www.santen.eu/index/news/07052008_Santen_Oy_Receives_Marketing_Authorization.html |dead-url=no }}</ref>。

==参考文献==
{{Reflist}}

{{抗青光眼制剂及缩瞳药}}
{{类花生酸类}}

{{pharma-stub}}
[[Category:前列腺素类|Category:前列腺素类]]